Abstract:Anti-cancer response of cell lines to drugs is in urgent need for individualized precision medical decision-making in the era of precision medicine. Measurements with wet-experiments is time-consuming and expensive and it is almost impossible for wide ranges of application. The design of computational models that can precisely predict the responses between drugs and cell lines could provide a credible reference for further research. Existing methods of response prediction based on matrix factorization or neural networks have revealed that both linear or nonlinear latent characteristics are applicable and effective for the precise prediction of drug responses. However, the majority of them consider only linear or nonlinear relationships for drug response prediction. Herein, we propose a Dual Branch Deep Neural Matrix Factorization (DBDNMF) method to address the above-mentioned issues. DBDNMF learns the latent representation of drugs and cell lines through flexible inputs and reconstructs the partially observed matrix through a series of hidden neural network layers. Experimental results on the datasets of Cancer Cell Line Encyclopedia (CCLE) and Genomics of Drug Sensitivity in Cancer (GDSC) show that the accuracy of drug prediction exceeds state-of-the-art drug response prediction algorithms, demonstrating its reliability and stability. The hierarchical clustering results show that drugs with similar response levels tend to target similar signaling pathway, and cell lines coming from the same tissue subtype tend to share the same pattern of response, which are consistent with previously published studies. As is known, the phenotype of cancer is closely related to gene expression in the human body. In the era of precision medicine, an increasing amount of anti-cancer drug response data is urgently needed for individualized therapy. Measurements with wet-experiments are time-consuming and costly, and computational methods are necessary. Existing methods mainly focused predominantly on linear or nonlinear relationships between cells and drugs for prediction. However, it has been shown that both linear and nonlinear relationships could contribute to more precise response prediction. Here, we propose a Dual Branch Deep Neural Matrix Factorization (DBDNMF) method to better use both linear and nonlinear relationships and the experimental results show that it outperforms state-of-the-art algorithms. Our results suggest that drugs showing similar response levels tend to target similar signaling pathways while cell lines sharing similar response patterns tend to come from the same tissue subtype. The analysis of experimental results may benefit medical decision-making.

Efficient modelling of channel maps with correlated shadow fading in mobile radio systems

MMDRP: drug response prediction and biomarker discovery using multi-modal deep learning

Drug Sensitivity Prediction Based on Multi-stage Multi-modal Drug Representation Learning

DRN-CDR: A cancer drug response prediction model using multi-omics and drug features

[Study on the method of using ICP-MS to determine Se in the edible fungi].

DeepCDR: a Hybrid Graph Convolutional Network for Predicting Cancer Drug Response

XMR: an explainable multimodal neural network for drug response prediction

Interpretable Drug Response Prediction through Molecule Structure-aware and Knowledge-Guided Visible Neural Network

A multi-view multi-omics model for cancer drug response prediction

LABORATORY.

GPDRP: a multimodal framework for drug response prediction with graph transformer

Deep learning and multi-omics approach to predict drug responses in cancer

DBDNMF: A Dual Branch Deep Neural Matrix Factorization method for drug response prediction

TCR: A Transformer Based Deep Network for Predicting Cancer Drugs Response

Decoding Drug Response with Structurized Gridding Map-based Cell Representation.

DualGCN: a dual graph convolutional network model to predict cancer drug response

Deep learning assisted multi-omics integration for survival and drug-response prediction in breast cancer

DeepTTA: a transformer-based model for predicting cancer drug response

Deep learning-based multi-drug synergy prediction model for individually tailored anti-cancer therapies

TransCDR: a deep learning model for enhancing the generalizability of cancer drug response prediction through transfer learning and multimodal data fusion for drug representation

TransCDR: a deep learning model for enhancing the generalizability of drug activity prediction through transfer learning and multimodal data fusion